AI assistant
Sending…
LABCORP HOLDINGS INC. — Director's Dealing 2023
Feb 14, 2023
30237_dirs_2023-02-14_d0e242e5-8eb7-4983-b902-a424f2f71941.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2023-02-11
Reporting Person: Summy Amy B. (EVP, Chief Marketing Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-02-11 | Common Stock | M | 180 | — | Acquired | 757 | Direct |
| 2023-02-13 | Common Stock | F | 54 | $248.13 | Disposed | 703 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-02-11 | Restricted Stock Unit | $ | M | 180 | Disposed | Common Stock (180) | Direct |
Footnotes
F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2: Stock withholding to satisfy tax withholding obligations.
F3: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2023.
F4: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
More from LABCORP HOLDINGS INC.
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 4
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Mar 30
Director's Dealing
2026
Mar 30
Director's Dealing
2026
Mar 30